乳酸作为瘤微环境中的代谢调节剂:将免疫抑制与表观遗传重编程联系起来
Weiwen Cheng1, Pengwei Lai1, Xinyuan Liu1
1Department of Anesthesiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China.
Current pharmaceutical biotechnology
|October 20, 2025
概括
通过华堡效应产生的乳酸,作为一个信号分子,在瘤微环境 (TME) 中抑制抗瘤免疫力. 向乳酸代谢为新型癌症疗法提供了一个有前途的战略.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 免疫学 免疫学 免疫学
背景情况:
- 瘤细胞表现出有氧糖解 (华堡效应),产生乳酸盐.
- 乳酸盐越来越被认为是癌症进展中的关键信号分子.
- 乳酸盐在瘤微环境 (TME) 中显著影响免疫细胞功能.
研究的目的:
- 综合当前关于TME中乳酸介导免疫调节的知识.
- 审查乳酸依赖性瘤生物学最近的进展.
- 评估针对乳酸代谢的治疗策略.
主要方法:
- 文献综述和现有研究的综合.
- 分析乳酸在免疫细胞功能和表观遗传调节中的作用.
- 评估乳酸代谢中的新兴治疗点.
主要成果:
- 乳酸盐抑制抗瘤免疫因子 (NK细胞,DC细胞,CTL细胞) 并增强免疫抑制细胞 (Tregs,TAM细胞,内皮细胞).
- 乳酸酸促进瘤免疫逃避,进展和转移.
- 氨酸乳化 (Kla) 揭示了瘤代谢和表观遗传调节之间的联系.
结论:
- 乳酸在调节TME,促进免疫抑制和瘤进展方面发挥着关键的双重作用.
- 了解乳酸的代谢和表观遗传功能对于开发新的癌症疗法至关重要.
- 针对乳酸代谢及其与表观遗传调节的交叉交互是一个有前途的治疗途径.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K

